<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03567031</url>
  </required_header>
  <id_info>
    <org_study_id>#2017-1309</org_study_id>
    <nct_id>NCT03567031</nct_id>
  </id_info>
  <brief_title>Impact of CO2 on Cerebral Blood Flow in Infants Less Than 6 Months During General Anaesthesia</brief_title>
  <official_title>Impact of CO2 on Cerebral Blood Flow in Infants Less Than 6 Months During General Anaesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Justine's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Justine's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims at assessing cerebral blood flow variations following expired CO2 variations
      in anaesthetized infants less than 6 months, during a routine general anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study aims at assessing cerebral blood flow (measured with Near-Infrared Reflectance
      Spectroscopy - NIRS - and transcranial Doppler - DTC) variations following end-tidal expired
      CO2 variations in anaesthetized infants less than 6 months, during a routine general
      anesthesia performed according to standards of care.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 27, 2017</start_date>
  <completion_date type="Actual">March 3, 2019</completion_date>
  <primary_completion_date type="Actual">March 3, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Cerebral blood flow is measured in each patient at 3 different, controlled levels of end-tidal CO2</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Patient is under general anesthesia</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>NIRS variation</measure>
    <time_frame>5 to 10 minutes</time_frame>
    <description>Near-Infrared Spectroscopy value variation after EtCO2 modification</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>DTC variation</measure>
    <time_frame>5 to 10 minutes</time_frame>
    <description>Transcranial Doppler values variation after EtCO2 modification</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Anesthesia, General</condition>
  <condition>Infant</condition>
  <arm_group>
    <arm_group_label>Main Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In each patient, under ongoing standard general anesthesia in a stable state, EtCO2 is manually modified to reach predefined values, and after waiting until cerebral blood flow has reached steady state, NIRS and DTC values are noted.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EtCO2 modification</intervention_name>
    <description>Controlled modification of EtCO2 through modification of ventilation parameters under general anesthesia without spontaneous breathing</description>
    <arm_group_label>Main Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &lt; or = 6 months

          -  ASA class &lt; or = 3

          -  General anesthesia required for surgery

        Exclusion Criteria:

          -  No parental consent

          -  Emergency surgery

          -  Preexisting neurological condition

          -  Hemodynamic instability

          -  Preexisting hypoxemia and/or hypercapnia

          -  Laparoscopy or thoracoscopy, if expected EtCO2 level achieving would require unsafe
             ventilation parameters
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruno Greff, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sainte Justine's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ossam Rhondali, MD</last_name>
    <role>Study Director</role>
    <affiliation>Sainte Justine's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose Luis Martinez, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Sainte Justine's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chantal Crochetière, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Sainte Justine's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Valérie Gaspard, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Sainte Justine's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sainte Justine's Hospital</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H3T 1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>May 23, 2018</study_first_submitted>
  <study_first_submitted_qc>June 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 25, 2018</study_first_posted>
  <last_update_submitted>October 2, 2019</last_update_submitted>
  <last_update_submitted_qc>October 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Justine's Hospital</investigator_affiliation>
    <investigator_full_name>Bruno Greff</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Pediatric Anesthesia</keyword>
  <keyword>Near-Infrared Spectroscopy</keyword>
  <keyword>End-Tidal CO2</keyword>
  <keyword>Cerebral Blood Flow</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Informed Consent Form</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 13, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/31/NCT03567031/Prot_ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

